72 related articles for article (PubMed ID: 17207895)
1. Suppression of food intake by a complement C3a agonist [Trp5]-oryzatensin(5-9).
Ohinata K; Suetsugu K; Fujiwara Y; Yoshikawa M
Peptides; 2007 Mar; 28(3):602-6. PubMed ID: 17207895
[TBL] [Abstract][Full Text] [Related]
2. Activation of prostaglandin E receptor EP4 subtype suppresses food intake in mice.
Ohinata K; Suetsugu K; Fujiwara Y; Yoshikawa M
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):31-6. PubMed ID: 16997129
[TBL] [Abstract][Full Text] [Related]
3. Arg-Ile-Tyr (RIY) derived from rapeseed protein decreases food intake and gastric emptying after oral administration in mice.
Marczak ED; Ohinata K; Lipkowski AW; Yoshikawa M
Peptides; 2006 Sep; 27(9):2065-8. PubMed ID: 16647789
[TBL] [Abstract][Full Text] [Related]
4. Orally administered novokinin, an angiotensin AT2 receptor agonist, suppresses food intake via prostaglandin E2-dependent mechanism in mice.
Ohinata K; Fujiwata Y; Shingo F; Masaru I; Masatsugu H; Yoshikawa M
Peptides; 2009 Jun; 30(6):1105-8. PubMed ID: 19463743
[TBL] [Abstract][Full Text] [Related]
5. beta-Lactotensin derived from bovine beta-lactoglobulin suppresses food intake via the CRF system followed by the CGRP system in mice.
Hou IC; Yoshikawa M; Ohinata K
Peptides; 2009 Dec; 30(12):2228-32. PubMed ID: 19720102
[TBL] [Abstract][Full Text] [Related]
6. Intracerebroventricularly administered urocortin inhibits gastric emptying in mice.
Nagata T; Uemoto M; Yuzuriha H; Asakawa A; Inui A; Fujimiya M; Sakamaki R; Kasuga M; Shinfuku N
Int J Mol Med; 2005 Jun; 15(6):1041-3. PubMed ID: 15870911
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II and III suppress food intake via angiotensin AT(2) receptor and prostaglandin EP(4) receptor in mice.
Ohinata K; Fujiwara Y; Fukumoto S; Iwai M; Horiuchi M; Yoshikawa M
FEBS Lett; 2008 Mar; 582(5):773-7. PubMed ID: 18258202
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of chicken gonadotropin-releasing hormone II on food intake in the goldfish, Carassius auratus.
Matsuda K; Nakamura K; Shimakura S; Miura T; Kageyama H; Uchiyama M; Shioda S; Ando H
Horm Behav; 2008 Jun; 54(1):83-9. PubMed ID: 18342861
[TBL] [Abstract][Full Text] [Related]
10. Studies on the ileum-contracting mechanisms and identification as a complement C3a receptor agonist of oryzatensin, a bioactive peptide derived from rice albumin.
Takahashi M; Moriguchi S; Ikeno M; Kono S; Ohata K; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
Peptides; 1996; 17(1):5-12. PubMed ID: 8822503
[TBL] [Abstract][Full Text] [Related]
11. The anorectic effect of neurotensin is mediated via a histamine H1 receptor in mice.
Ohinata K; Shimano T; Yamauchi R; Sakurada S; Yanai K; Yoshikawa M
Peptides; 2004 Dec; 25(12):2135-8. PubMed ID: 15572202
[TBL] [Abstract][Full Text] [Related]
12. Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents.
Saleh J; Blevins JE; Havel PJ; Barrett JA; Gietzen DW; Cianflone K
Int J Obes Relat Metab Disord; 2001 May; 25(5):705-13. PubMed ID: 11360154
[TBL] [Abstract][Full Text] [Related]
13. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents.
Gourcerol G; Coskun T; Craft LS; Mayer JP; Heiman ML; Wang L; Million M; St-Pierre DH; Taché Y
Obesity (Silver Spring); 2007 Nov; 15(11):2643-52. PubMed ID: 18070755
[TBL] [Abstract][Full Text] [Related]
14. Albutensin A and complement C3a decrease food intake in mice.
Ohinata K; Inui A; Asakawa A; Wada K; Wada E; Yoshikawa M
Peptides; 2002 Jan; 23(1):127-33. PubMed ID: 11814627
[TBL] [Abstract][Full Text] [Related]
15. Central prostaglandin D(2) stimulates food intake via the neuropeptide Y system in mice.
Ohinata K; Takagi K; Biyajima K; Fujiwara Y; Fukumoto S; Eguchi N; Urade Y; Asakawa A; Fujimiya M; Inui A; Yoshikawa M
FEBS Lett; 2008 Mar; 582(5):679-84. PubMed ID: 18258196
[TBL] [Abstract][Full Text] [Related]
16. Designing of an orally active complement C3a agonist peptide with anti-analgesic and anti-amnesic activity.
Jinsmaa Y; Takenaka Y; Yoshikawa M
Peptides; 2001 Jan; 22(1):25-32. PubMed ID: 11179594
[TBL] [Abstract][Full Text] [Related]
17. Central administration of insulin suppresses food intake in chicks.
Honda K; Kamisoyama H; Saneyasu T; Sugahara K; Hasegawa S
Neurosci Lett; 2007 Aug; 423(2):153-7. PubMed ID: 17693022
[TBL] [Abstract][Full Text] [Related]
18. The effects of intraperitoneal administration of the GABA(B) receptor agonist baclofen on food intake in CFLP and C57BL/6 mice.
Ebenezer IS; Prabhaker M
Eur J Pharmacol; 2007 Aug; 569(1-2):90-3. PubMed ID: 17597601
[TBL] [Abstract][Full Text] [Related]
19. Orally administered FPRL1 receptor agonist peptide MMK-1 inhibits etoposide-induced alopecia by a mechanism different from intraperitoneally administered MMK-1.
Tsuruki T; Yoshikawa M
Peptides; 2006 Apr; 27(4):820-5. PubMed ID: 16183167
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity.
Balasubramaniam A; Mullins DE; Lin S; Zhai W; Tao Z; Dhawan VC; Guzzi M; Knittel JJ; Slack K; Herzog H; Parker EM
J Med Chem; 2006 Apr; 49(8):2661-5. PubMed ID: 16610810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
